BILIARY CANCERS

Clinical trials for BILIARY CANCERS explained in plain language.

Never miss a new study

Get alerted when new BILIARY CANCERS trials appear

Sign up with your email to follow new studies for BILIARY CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug INV-8989 targets Hard-to-Treat cancers with KRAS G12D mutation

Disease control Recruiting now

This study tests a new drug called INV-8989 in people with advanced solid tumors that have a specific genetic change called KRAS G12D. The trial has two phases: the first finds the safest dose, and the second checks how well the drug shrinks tumors. About 178 adults with cancers …

Matched conditions: BILIARY CANCERS

Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:05 UTC

BILIARY CANCERS

Get alerted when new BILIARY CANCERS trials appear

New drug INV-8989 targets Hard-to-Treat cancers with KRAS G12D mutation